(Press-News.org) New research reveals that bilingualism has a positive effect on cognition later in life. Findings published in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, show that individuals who speak two or more languages, even those who acquired the second language in adulthood, may slow down cognitive decline from aging.
Bilingualism is thought to improve cognition and delay dementia in older adults. While prior research has investigated the impact of learning more than one language, ruling out "reverse causality" has proven difficult. The crucial question is whether people improve their cognitive functions through learning new languages or whether those with better baseline cognitive functions are more likely to become bilingual.
"Our study is the first to examine whether learning a second language impacts cognitive performance later in life while controlling for childhood intelligence," says lead author Dr. Thomas Bak from the Centre for Cognitive Aging and Cognitive Epidemiology at the University of Edinburgh.
For the current study, researchers relied on data from the Lothian Birth Cohort 1936, comprised of 835 native speakers of English who were born and living in the area of Edinburgh, Scotland. The participants were given an intelligence test in 1947 at age 11 years and retested in their early 70s, between 2008 and 2010. Two hundred and sixty two participants reported to be able to communicate in at least one language other than English. Of those, 195 learned the second language before age 18, 65 thereafter.
Findings indicate that those who spoke two or more languages had significantly better cognitive abilities compared to what would be expected from their baseline. The strongest effects were seen in general intelligence and reading. The effects were present in those who acquired their second language early as well as late.
The Lothian Birth Cohort 1936 forms the Disconnected Mind project at the University of Edinburgh, funded by Age UK. The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1) and has been made possible thanks to funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC).
"The Lothian Birth Cohort offers a unique opportunity to study the interaction between bilingualism and cognitive aging, taking into account the cognitive abilities predating the acquisition of a second language" concludes Dr. Bak. "These findings are of considerable practical relevance. Millions of people around the world acquire their second language later in life. Our study shows that bilingualism, even when acquired in adulthood, may benefit the aging brain."
After reviewing the study, Dr. Alvaro Pascual-Leone, an Associate Editor for Annals of Neurology and Professor of Medicine at Harvard Medical School in Boston, Mass. said, "The epidemiological study by Dr. Bak and colleagues provides an important first step in understanding the impact of learning a second language and the aging brain. This research paves the way for future causal studies of bilingualism and cognitive decline prevention."
INFORMATION:
This study is published in Annals of Neurology. Media wishing to receive a PDF of this article may contact sciencenewsroom@wiley.com
Full citation: "Does Bilingualism Influence Cognitive Aging?" Thomas H Bak, Jack J Nissan, Michael M Allerhand and Ian J Deary. Annals of Neurology; Published Online: June 2, 2014 (DOI:10.1002/ana.24158).
URL Upon Publication: http://doi.wiley.com/10.1002/ana.24158
Author Contact: To arrange an interview with Dr. Bak, please contact Joanne Morrison with the University of Edinburgh at Joanne.Morrison@ed.ac.uk.
About the Journal
Annals of Neurology, the official journal of the American Neurological Association and the Child Neurology Society, publishes articles of broad interest with potential for high impact in understanding the mechanisms and treatment of diseases of the human nervous system. All areas of clinical and basic neuroscience, including new technologies, cellular and molecular neurobiology, population sciences, and studies of behavior, addiction, and psychiatric diseases are of interest to the journal. The journal is published by Wiley on behalf of the American Neurological Association and Child Neurology Society. For more information, please visit http://onlinelibrary.wiley.com/journal/10.1002/ana.
About Wiley
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's website can be accessed at http://www.wiley.com.
Speaking 2 languages benefits the aging brain
2014-06-02
ELSE PRESS RELEASES FROM THIS DATE:
Myriad myPath melanoma test improves the reliability of melanoma diagnosis
2014-06-02
SALT LAKE CITY, Utah, June 2, 2014 – Myriad Genetics, Inc. (Nasdaq: MYGN) today presented results from a pivotal clinical validation study of the Myriad myPath™ Melanoma test at the 2014 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Ill. The Myriad myPath Melanoma test is a novel molecular test that accurately differentiates malignant melanoma from benign skin lesions with a high level of accuracy and helps physicians deliver a more objective and confident diagnosis for patients.
"Unfortunately, some melanomas mimic benign skin lesions, making ...
Myriad presents clinical data on Myriad myRisk Hereditary Cancer Test at ASCO
2014-06-02
SALT LAKE CITY, Utah, June 2, 2014 – Myriad Genetics, Inc. (Nasdaq: MYGN) today presented several clinical studies on the Myriad myRisk™ Hereditary Cancer test at the 2014 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois. Among the important new findings is that the myRisk test detects significantly more deleterious mutations than single cancer tests and helps solve the overlap dilemma that exists among hereditary cancer syndromes.
"There is robust evidence that hereditary cancers are caused by mutations in many genes and testing for only ...
Physics in Brazil takes center stage as World Cup comes to town
2014-06-02
As Brazil gets set to host the 2014 FIFA World Cup this month amid concerns about the amount of public money being used to stage the world's largest sporting event, Physics World's editorial team reveals in a new special report how physicists are taking full advantage of the four-fold increase in science funding that the government has invested over the past 10 years.
Negotiations are currently under way to make Brazil an associate member of the CERN particle-physics lab in Geneva, while the country is also taking a leading role in the Pierre Auger Observatory – an international ...
Deletions and duplications in the exome can help pinpoint cause of unexplained genetic diseases
2014-06-02
Analysis of genetic variation in the exome, the DNA sequence of genes that are translated into protein, can aid in uncovering the cause of conditions for which no genetic cause could previously be found, and this can directly impact clinical management, the annual conference of the European Society of Human Genetics will hear today. Dr Jayne Hehir-Kwa, Assistant Professor of Bioinformatics in the Translational Research group, Department of Human Genetics, Radboud UMC, Nijmegen, The Netherlands, will describe results from her group's study that set out to determine whether ...
New genes involved in food preferences will revolutionize diets and improve health
2014-06-02
New understanding of the genes involved in taste perception and food preferences could lead to personalised nutrition plans effective not just in weight loss but in avoiding diseases such as cancer, depression, and hypertension, Italian researchers will tell the annual conference of the European Society of Human Genetics (ESHG) today (Monday). Knowing why individuals prefer certain food tastes and being able to personalise health interventions based on them will help people age in a healthier way and greatly improve their quality of life, as well as engender considerable ...
New research shows parental presence improves the quality of child anesthesia
2014-06-02
New research presented at this year's Euroanaesthesia meeting in Stockholm shows that having parents present during the induction of their child's anaesthesia improves the quality of that anaesthesia. The study is by Dr Alicia Sánchez, Department of Anaesthesiology, Hospital de Sagunto, Spain, and colleagues.
Induction of anaesthesia can be distressing for parents and children. The effect of parental presence at anaesthesia induction on children anxiety and children anaesthesia compliance has been previously investigated but the few studies to date have produced contradictory ...
Improving bystander resuscitation following cardiac arrest outside hospital could save 100,000 lives across Europe each year
2014-06-02
A session at this year's Euroanaesthesia meeting will discuss how improving the skills of members of the public, including schoolchildren, in resuscitation following cardiac arrest could save up to 100,000 lives per year. The presentation will be given by Professor Bernd Böttiger, Director of Science and Research at the European Resuscitation Council (ERC), and also Head of the Department of Anaesthesiology and Intensive Care Medicine at University Hospital Cologne, Germany.
The best estimates currently available suggest that 350,000 deaths in each year in Europe are ...
Children exposed to secondhand tobacco or cooking smoke have very high rates of pain and complications after tonsillectomy
2014-06-02
New research presented at this year's Euroanaesthesia meeting in Stockholm shows that children exposed to indoor coal-burning stoves and/or second-hand tobacco smoke are much more likely to suffer postoperative complications and excessive pain after tonsillectomies. The research is by Professor Daniel Sessler, Cleveland Clinic, Cleveland, Ohio, USA and Dr Onur Koyuncu, Mustafa Kemal University, Hatay, Turkey, and colleagues.
Almost half of the world's population uses solid fuel including biomass (wood, crop residues, and animal dung) or coal for heating and cooking. ...
A single DNA tweak leads to blond hair
2014-06-01
A single-letter change in the genetic code is enough to generate blond hair in humans, in dramatic contrast to our dark-haired ancestors. A new analysis by Howard Hughes Medical Institute (HHMI) scientists has pinpointed that change, which is common in the genomes of Northern Europeans, and shown how it fine-tunes the regulation of an essential gene.
"This particular genetic variation in humans is associated with blond hair, but it isn't associated with eye color or other pigmentation traits," says David Kingsley, an HHMI investigator at Stanford University who led the ...
How to erase a memory -- and restore it
2014-06-01
Researchers at the University of California, San Diego School of Medicine have erased and reactivated memories in rats, profoundly altering the animals' reaction to past events.
The study, published in the June 1 advanced online issue of the journal Nature, is the first to show the ability to selectively remove a memory and predictably reactivate it by stimulating nerves in the brain at frequencies that are known to weaken and strengthen the connections between nerve cells, called synapses.
"We can form a memory, erase that memory and we can reactivate it, at will, ...